arrow
L

Lukas Hartl

Medical University of Vienna
H指数:24
被引数:2,002

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Circulating fibronectin levels are linked to liver function, matrix remodeling, and hemostatic complications in advanced chronic liver disease

循环纤维连接蛋白水平与晚期慢性肝病中的肝功能、基质重塑和止血并发症相关

2026-09-250
OA
Course of Portal Hypertension and Its Prognostic Impact After Liver Transplantation

门静脉高压症的发展过程及其肝移植后的预后影响

2026-08-100
OAAI
Post-TIPS Dynamics of von Willebrand Factor for Risk Stratification After TIPS Placement

经颈静脉肝内门体分流术(TIPS)后血管性血友病因子动力学用于分流术后风险分层

2026-06-080
OA
Prognostication of Liver Disease Patients via the WFUMB ‘Rule-of-4’ Algorithm Using SSI-2D-SWE-Based Liver Stiffness Measurement

基于SSI-2D-SWE肝脏硬度测量的WFUMB‘4规则’算法对肝病患者的预后预测

2026-04-090
OAAI
Correlation of Bile Acid Dynamics to Bulevirtide Response and Disease Severity in Patients With Hepatitis D

胆汁酸动力学与丁型肝炎患者中布立韦妥司他应答及疾病严重程度的相关性

2026-04-011
OAAI
Response-guided bulevirtide ± pegylated interferon alfa-2a: long-term outcomes observed in the nationwide Austrian hepatitis D cohort study

应答指导下的bulevirtide±聚乙二醇干扰素α-2a:在奥地利全国性丁型肝炎队列研究中观察到的长期结局

2026-03-260
OAAI
Non-invasive tests to guide hepatocellular carcinoma surveillance☆

指导肝细胞癌监测 ☆ 的非侵入性测试

2026-01-230
OAAI
The Alpha-1 Pi*MZ Genotype Is an Independent Risk Factor for Hepatocellular Carcinoma Development in Patients With ACLD
2026-01-230
OAAI
GDF-15 Levels in Cirrhosis Are Linked to Hepatic Fibrogenesis, Bacterial Translocation, and Worse Clinical Outcomes
2026-01-190
OAAI
Indocyanine Green Clearance Correlates With Biomarkers Reflecting Key Disease-Driving Mechanisms in Advanced Chronic Liver Disease and Predicts Acute-on-Chronic Liver Failure and Death

靛青绿清除率与反映晚期慢性肝病关键疾病驱动机制的生物标志物相关,并可预测急性-慢性肝功能衰竭及死亡。

2025-11-050
OAAI
Alcohol Use After TIPS Implantation Significantly Increases the Risk of ACLF and Liver-Related Death

TIPS植入术后饮酒显著增加ACLF和肝脏相关死亡的风险

2025-11-011
PRE
Blood-based Vienna 3P/5P risk models accurately predict first hepatic decompensation in compensated advanced chronic liver disease

基于血液的维也纳3P/5P风险模型可准确预测代偿期晚期慢性肝病患者的首次肝功能失代偿。

2025-10-170
OAAI
Treatment response to bulevirtide is linked to amelioration of portal hypertension in patients with chronic hepatitis D☆

布勒韦尔肽的治疗反应与慢性丁型肝炎患者门静脉高压的改善相关。

2025-10-170
OAAI
Biomarkers of Extracellular Matrix Remodelling Are Linked to Severity and Outcome of Advanced Chronic Liver Disease

细胞外基质重塑的生物标志物与晚期慢性肝病的严重程度和预后相关

2025-10-120
OAAI
Pre-emptive TIPS should be considered in high-risk patients with both acute variceal bleeding and severe alcohol-related hepatitis

对于同时患有急性静脉曲张出血和严重酒精性肝病的危重患者,应考虑进行预防性TIPS治疗。

2025-09-290
OAAI
Neutrophil Extracellular Traps Are Not Linked to Decompensation, ACLF, or Death in Clinically Stable Patients With ACLD

中性粒细胞胞外陷阱与临床稳定的ACLD患者的失代偿、ACLF或死亡无关

2025-09-180
OAAI